Active, not recruitingNot applicableNCT07165977

Anti-inflammatory Probiotics in Cognitive Functioning

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Social Sciences and Humanities, Warsaw
Intervention
Probiotic Supplementation (Bifidobacterium longum Rosell®-175 & Lactobacillus helveticus Rosell®-52) then placebo(dietary_supplement)
Enrollment
110 enrolled
Eligibility
50 years · All sexes
Timeline
2024 – 2026

Study locations (1)

Collaborators

Sanprobi Sp. z o. o. · National Science Centre, Poland

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07165977 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease →

← Back to all trials